ArticleRSC advances2026
PLA/BC/lard nanofiber composites as next-generation burn wound dressings.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study describes the development of electrospun nanofibers composed of polylactic acid (PLA), bacterial cellulose (BC), and lard for wound dressing applications. PLA provided structural stability, BC enhanced hydrophilicity and mechanical reinforcement, while lard contributed elasticity and biofunctionality. Morphological analysis showed uniform, bead-free fibers; BC incorporation reduced fiber diameter, while lard incorporation increased fiber thickness due to its plasticizing effect on the polymer matrix. Mechanical tests revealed that PLA/BC composites exhibited higher tensile strength, while PLA/BC/lard composites showed greater elongation at break and elasticity, making them suitable for dynamic anatomical regions; numerical analyses confirmed the high reliability of the structural modeling by showing a maximum deviation of 1.57% between experimental and theoretical stress values. Biological evaluations with human dermal fibroblasts confirmed high biocompatibility. PLA/BC/lard nanofibers promoted cell viability, accelerated wound closure, and exhibited a reduction trend in pro-inflammatory cytokines (IL-6 and IL-17) compared to PLA/BC controls, suggesting a non-significant trend of lard incorporation. In conclusion, the synergistic integration of PLA, BC, and lard produced multifunctional nanofibers with balanced mechanical properties, biodegradability, and biological activity. To the best of our knowledge, this is the first study reporting lard-containing PLA/BC nanofibers, highlighting their novelty and potential as next-generation wound dressings with improved early healing-related responses and a non-significant downward trend in pro-inflammatory cytokine levels.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.